Sage Therapeutics Inc.

NASDAQ: SAGE · Real-Time Price · USD
8.68
0.00 (0.00%)
At close: Jul 30, 2025, 3:59 PM

Sage Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-49.65M -62.21M -95.78M -93.55M -102.85M -108.48M -32.71M -201.63M -160.32M -146.83M -147.15M -137.32M -126.26M -122.06M -124.71M -130.17M -107.25M -95.76M
Depreciation & Amortization
-442K -981K 129K 255K 311K 336K 409K 330K 331K 323K 290K 278K 279K 275K 333K 374K 893K 2.58M
Stock-Based Compensation
8.73M 6.93M 9.43M 14.21M 17.17M 13.7M 12.95M 28.69M 11.69M 20.04M 15.24M 13.17M 14.64M 18.55M 20.65M 34.34M 27.66M 21.98M
Other Working Capital
18.17M -18.17M 9.45M 5.27M 4.25M -10.47M -105.47M 39.8M 24.23M 6.55M -5.75M 2.08M 4.56M -3.67M 108K 23.7M -19.66M -29.34M
Other Non-Cash Items
-42.76M -25K -1.1M -2.1M 13M -55.87M 6.12M -4.95M -4.43M -3.21M -1.36M 1.06M 2.32M 2.34M 475K 1.11M -4.05M -8.13M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
25.43M -25.43M 20.76M -1.18M 6.99M 58.19M -106.29M 41.69M 21.22M -24.01M 6.04M 3.95M 2.59M -6.92M 5.75M 25.51M -20.03M -29.75M
Operating Cash Flow
-58.69M -81.73M -66.56M -82.36M -80.44M -37.83M -119.52M -135.87M -131.52M -153.68M -126.93M -118.86M -106.44M -107.8M -97.5M -68.83M -102.77M -109.09M
Capital Expenditures
n/a n/a n/a n/a n/a n/a 112K -328K -112K -225K -282K -364K -122K -169K -372K n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -41.95M -160.72M -45.7M -195.09M -90.06M -111.32M -134.38M n/a n/a n/a n/a n/a
Purchase of Investments
-68.6M -87.97M -88.7M -102.32M -198.32M -61.62M -134.96M -70.06M -232.76M -156.89M -198.53M -251.4M -129.18M -301.93M -318.75M -363.26M -466.36M -841.79M
Sales Maturities Of Investments
149.62M 133.76M 135.28M 183.37M 197.93M 201.05M 176.91M 230.78M 278.47M 351.98M 288.59M 362.72M 263.56M 292.54M 288.86M 338.27M 177.97M 182.97M
Other Investing Acitivies
n/a n/a n/a n/a -386K 139.44M 41.95M 160.72M 45.7M 195.09M 90.06M 111.32M 134.38M -9.39M -29.89M -24.98M -288.39M -658.82M
Investing Cash Flow
81.02M 45.78M 46.57M 81.05M -386K 139.44M 42.06M 160.39M 45.59M 194.87M 89.78M 110.95M 134.26M -9.56M -30.26M -24.98M -288.39M -658.82M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a 3K -1K -2K -262K -4K -8K -629K -4K -15K -24K n/a -589K n/a -796K n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-65K 148K -2K 1.04M 8.07M 1.56M -262K 2.77M 847K 2.67M 29K 1.23M 13K 1.8M -170K 1.82M 6.07M 5.62M
Financial Cash Flow
-65K 148K -2K 1.04M 8.07M 1.56M -262K 2.77M 847K 2.67M 29K 1.23M 13K 1.8M -170K 1.82M 6.07M 5.62M
Net Cash Flow
22.26M -35.8M -19.99M 1.23M -72.75M 101.66M -77.72M 27.3M -85.08M 43.86M -37.13M -6.68M 27.84M -115.56M -127.93M -91.99M -385.09M -762.28M
Free Cash Flow
-58.69M -81.73M -66.56M -82.36M -80.44M -37.83M -119.41M -136.19M -131.63M -153.91M -127.21M -119.23M -106.56M -107.97M -97.87M -68.83M -102.77M -109.09M